Everyone Healthy Library
Fungal Urinary Tract Infections
Condition / disease reference page from the Everyone Healthy database.
! Seek urgent medical care if warning signs appear
Some health conditions or symptoms can become urgent. Use this page for education, but seek help quickly if warning signs are present.
Get urgent medical care now if there is any severe, sudden, rapidly worsening or worrying symptom, especially:
- chest pain, pressure or pain spreading to the arm, jaw or back
- trouble breathing, blue lips, severe wheeze or choking
- stroke-like symptoms such as face drooping, arm weakness or speech trouble
- collapse, fainting, seizure, confusion or extreme drowsiness
- severe bleeding, black stools, vomiting blood or major injury
- severe allergic reaction, swelling of the face/throat or widespread rash with breathing trouble
- severe abdominal pain, severe headache, stiff neck or sudden vision change
- signs of severe dehydration, sepsis, high fever with worsening illness, or symptoms in a baby/young child that concern you
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
7Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
1Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
18Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Medical therapy
2Alternative and complementary therapies
6- Echinacea PurpureaNo Recommendation(Moderate Evidence)
- Goldenseal (Hydrastis Canadensis)Weakly Against(Low Evidence)
- Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica)No Recommendation(Low Evidence)
- Kava (Piper Methysticum)No Recommendation(Very Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Pokeweed Antiviral Protein (PAP)No Recommendation(Very Low Evidence)
Alternative medicine
5- Goldenseal (Hydrastis Canadensis)Weakly Against(Low Evidence)
- Gotu Kola (Centella Asiatica, Hydrocotyle Asiatica)No Recommendation(Low Evidence)
- Kava (Piper Methysticum)No Recommendation(Very Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Pokeweed Antiviral Protein (PAP)No Recommendation(Very Low Evidence)
Vitamins and minerals
1Vitamins
1Linked diagnostic tests and investigations
31These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Alpha-1 Antitrypsin (AAT) Concentration
- Cerebrospinal Fluid Albumin Concentration
- Cerebrospinal Fluid Glucose Concentration
- Cerebrospinal Fluid Protein Concentration
- Cerebrospinal Fluid Protein Electrophoresis
- Cerebrospinal Fluid White Cell Differential
- Chloride Concentration (Blood)
- Cholesterol Concentration
- Cholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- D-Dimer Blood Test
- Ferritin Concentration
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- Fibrinopeptide A (FPA) Action Assay
- Glucagon Concentration Test
- Glucose 6 Phosphate Dehydrogenase (G6PD) Concentration
- Glucose, Blood (Random Blood Glucose Test)
- haptoglobin (Hp) concentration
- Neutrophil Absolute Count
- Plasminogen Activity
- Potassium Concentration (K, Blood)
- Prostate-Specific Antigen (PSA) Blood Test
- Protein Electrophoresis (Blood, Serum Protein)
- Urine Crystal Concentration
- Urine glucose concentration
- Urine Granular Cast Concentration
- Urine Haemologlobin (Hb) Concentration
- Urine Leukocyte Esterase Screening
- Urine pH Test
- Urine Red Blood Cells Concentration
- White Blood Cell (WBC) Count
Biological markers/agents
34This visual map shows biological markers/agents reported as increased or decreased with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
28- Albumin (Cerebrospinal Fluid, CSF)Reference range exampleAll: 10–35 mg/dL; All: 56–76 %Linked diagnostic testsCerebrospinal Fluid Albumin Concentration, Cerebrospinal Fluid Protein Electrophoresis
- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic testsAlpha-1 Antitrypsin (AAT) Concentration
- Alpha-1-Globulin (Blood, Serum)Reference range exampleAll: 0.1–0.3 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- Alpha-2-Globulin (Blood, Serum)Reference range exampleAll: 0.6–1 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- Cerebrospinal Fluid LeukocytesReference range exampleAdult ( > 16y): 0–5 /µL; 1y - 6y: 0–20 /µLLinked diagnostic testsCerebrospinal Fluid White Cell Differential
- Cerebrospinal Fluid Total ProteinReference range exampleAdult ( > 16y): 15–45 mg/dL; Child (< 10y): 15–70 mg/dLLinked diagnostic testsCerebrospinal Fluid Protein Concentration
- Cholesterol (Total)Reference range exampleInfant (0 - 1y): 75–180 mg/dL; Adult ( > 16y): 0–190 mg/dLLinked diagnostic testsCholesterol Concentration
- D-DimerReference range exampleAdult ( > 16y): 0–240 µg/LLinked diagnostic testsD-Dimer Blood Test
- FerritinReference range exampleChild (0 - 16y): 7–140 µg/L; Adult ( > 16y), Female: 18–160 µg/LLinked diagnostic testsFerritin Concentration
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic testsFibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic testsFibrin Degradation Products (FDPs, Fibrin Split Products
- Fibrinopeptide A (FPA)Reference range exampleAdult ( > 16y), Female: 0.7–3.1 mg/mL; Adult ( > 16y), Male: 0.35–2.5 mg/mLLinked diagnostic testsFibrinopeptide A (FPA) Action Assay
- Forced Expiratory Volume At Three Seconds (FEV3)Reference range exampleAll: 95–100 %Linked diagnostic testsSpirometry
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic testsProtein Electrophoresis (Blood, Serum Protein)
- GlucagonReference range exampleChild (0 - 16y): 0–147 pg/mL; Adult ( > 16y): 20–110 pg/mLLinked diagnostic testsGlucagon Concentration Test
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic testshaptoglobin (Hp) concentration
- PlasminogenReference range exampleAdult ( > 16y), Female: 65–153 %; Adult ( > 16y), Male: 70–120 %Linked diagnostic testsPlasminogen Activity
- Potassium (K, Blood)AbbreviationKReference range exampleInfant (0 - 1y): 4.1–5.3 mEq/L; Child (0 - 16y): 3.4–4.7 mEq/LLinked diagnostic testsPotassium Concentration (K, Blood)
- PrealbuminReference range exampleAll: 2–7 %Linked diagnostic testsCerebrospinal Fluid Protein Electrophoresis
- Prostate Specific Antigen (PSA)Reference range exampleAdult ( > 16y), Male: 0–3.8 ng/mLLinked diagnostic testsProstate-Specific Antigen (PSA) Blood Test
- Triple Phosphate Crystals (Urine)Reference range exampleAll: 0–1 Not PresentLinked diagnostic testsUrine Crystal Concentration
- Unrine Granular CastsReference range exampleAdult ( > 16y): 0–0 Not PresentLinked diagnostic testsUrine Granular Cast Concentration
- Urine Crystals (Total)Reference range example0–2 /hpfLinked diagnostic testsUrine Crystal Concentration
- Urine glucoseReference range example0–2.5; Adult ( > 16y): 0–2.5 mmol/dayLinked diagnostic testsUrine glucose concentration
- Urine Haemoglobin (Hb)Reference range exampleAdult ( > 16y): 0–0.02 mg/dLLinked diagnostic testsUrine Haemologlobin (Hb) Concentration
- Urine Leukocyte EsteraseReference range exampleAll: 0–1 Not PresentLinked diagnostic testsUrine Leukocyte Esterase Screening
- Urine Red Blood CellsReference range exampleAdult ( > 16y): 0–2 /hpfLinked diagnostic testsUrine Red Blood Cells Concentration
- White Blood Cell (WBC)Reference range exampleAdult ( > 16y): 4.5–10.5 million/mL; Adult ( > 16y): 3.2–10 million/mLLinked diagnostic testsWhite Blood Cell (WBC) Count
Often decreased
6- Chloride (Blood, Cl)Reference range exampleAdult ( > 16y): 97–106 mEq/L; Birth - 2wks: 94–106 mEq/LLinked diagnostic testsChloride Concentration (Blood)
- CholinesteraseReference range exampleAll: 6–19 U/mLLinked diagnostic testsCholinesterase (Serum Acetylcholinesterase, Pseudocholinesterase)
- Glucose (Blood)Reference range exampleInfant (0 - 1y): 3–6.1 mmol/L; Adult ( > 16y): 0–6.1 mmol/LLinked diagnostic testsfasting Blood Glucose Test, Glucose Tolerance Test (GTT
- Glucose (Cerebrospinal Fluid)Reference range exampleChild (0 - 16y): 65–85 mg/dL; Adult ( > 16y): 50–72 mg/dLLinked diagnostic testsCerebrospinal Fluid Glucose Concentration
- Glucose 6 Phosphate Dehydrogenase (G6PD)Reference range exampleAdult ( > 16y): 10.1–18.5 U/gHb; Birth - 2wks: 12–23 U/gHbLinked diagnostic testsGlucose 6 Phosphate Dehydrogenase (G6PD) Concentration
- UrineReference range exampleAdult ( > 16y): 4.5–7.5; Child (0 - 16y): 500–1,400 mLLinked diagnostic testsUrine Colour, Urine Creatinine Concentration
Introduction / full article
Fungal Urinary Tract Infections
Fungal Urinary Tract Infections
Fungal urinary tract infections usually affect the kidneys and bladder. Fungal infection in the lower urinary tract is often associated with urinary catheter use and antibiotic therapy. There are rarely symptoms when someone has a fungal urinary tract infection in the lower urinary tract, though some patients experience pain while urinating or frequent urges to urinate. Traces of blood may also be found in the urine. One type of fungal urinary tract infection is renal candidiasis, which involves the gastrointestinal tract.
Efficacy of Alternative and Other Treatments According to GRADE* Ranking
Vitamin A [1, 31, 32, 33, 34, 35, 36, 37]
Please note, this management does not treat the condition itself. It may mildly help in preventing some symptoms, and even then has insufficient evidence to back up this claim at present. This acts as a preventative treatment, and not necessarily symptomatic relief.
Recommendation: Strongly in favor. Vitamin A may help to prevent urinary tract infections due to its role in the body's immune function.
Grade of Evidence: High quality of evidence.
Pokeweed Antiviral Protein (PAP) [1, 26, 27, 28, 29, 30]
Please note, this management does not treat the condition itself. It may mildly help with some symptoms, and even then has insufficient evidence to back up this claim at present. Warning: all parts of the pokeweed plant (Phytolacca americana) are poisonous and should not be ingested. Thorough cooking reduces toxicity. The effects of improperly prepared plant material may include vomiting, diarrhoea, cramps, headache, confusion, convulsions, low blood pressure, heart block, and death. Only plant extracts (PAP) or thoroughly prepared plants should be ingested, and even then, only under professional medical guidance.
Recommendation: No recommendation. There is insufficient evidence to support claims that PAP helps to treat fungal infections.
Grade of Evidence: Very low quality of evidence.
Pau D'Arco (Lapachol, Tabebuia impetiginosa, Tabebuia heptaphylla) [1, 25]
Please note, this treatment has potentially serious side effects. Some chemicals in the plant are known to be toxic. High doses are known to affect the liver and kidneys. Even at low doses, chemicals in the plant may interfere with blood clotting, causing excess bleeding and anaemia. Pau D'Arco should be avoided, especially by pregnant or breastfeeding women.
Recommendation: Strongly against. There is insufficient evidence to support claims that Pau D'Arco helps to treat fungal infections. Combined with its potentially harmful side effects if taken without supervision from a doctor or pharmacist, there is enough reason to avoid this treatment.
Grade of Evidence: Very low quality of evidence.
Kava (Piper methysticum) [1, 21, 22, 23, 24]
Warning: in rare cases, kava may lead to liver failure and other life-threatening problems. The FDA warns that people who have had liver problems, or who are taking medications that may affect the liver, should check with their doctors before taking kava. Other side effects include headache, upset stomach, drowsiness, weight loss, bloody urine, and muscle weakness.
Recommendation: No recommendation. There is insufficient evidence to support claims that kava helps to treat symptoms of fungal infection. More research is needed.
Grade of Evidence: Very low quality of evidence.
Gotu Kola (Centella asiatica, Hydrocotyle asiatica) [3, 15, 16, 17, 18, 19, 20]
Please note, this management does not treat the condition itself. It may mildly help with some symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: No recommendation. There is insufficient evidence to support claims that Gotu Kola helps in the treatment of fungal urinary tract infections in any way. More research is needed.
Grade of Evidence: Low quality of evidence.
Goldenseal (Hydrastis canadensis) [3, 8, 9, 10, 11, 12, 13, 14]
Please note, this management does not treat the condition itself. It may mildly help with some symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: Weakly against. There is insufficient evidence to support claims that Goldenseal helps to treat urinary tract infections. More studies are needed. Goldenseal may produce toxic effects, including depression, constipation, rapid heartbeat, stomach pain, mouth ulcers, and vomiting.
Grade of Evidence: Low quality of evidence.
Echinacea Purpurea [3, 4, 5, 6, 7]
Please note, this management does not treat the condition itself. It may mildly help with some symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: No recommendation. Evidence has shown that Echinacea has no effect in the treatment or prevention of urinary tract infections.
Grade of Evidence: Moderate quality of evidence.
* GRADE Working Group: www.gradeworkinggroup.org
Summary References
Treatments:
- Malani AN, Kauffman CA. Candida urinary tract infections: treatment options. Expert Review of Anti-Infective Therapy. 2007 Apr;5(2):277-84.
- Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World Journal of Urology. 1999 Dec;17(6):410-4.
- Ades T, Alteri R, Gansler T, Yeargin P. Complete Guide to Complementary & Alternative Cancer Therapies. American Cancer Society, Atlanta USA, 2009.
- American Cancer Society: Echinacea
- NCCAM: Echinacea at a glance
- PubMed PMID: 16049208
- Medical News Today: Echinacea
- American Cancer Society: Goldenseal
- NCCAM: Goldenseal
- Tierra M. The Way of Herbs. New York: Pocket Books; 1998.
- Grieve M. A Modern Herbal. New York: Dover Publications; 1971.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Philadelphia: Churchill Livingstone; 2000.
- Tice R. Goldenseal and Two of Its Constituent Alkaloids: Berberine and Hydrastine. Research Triangle Park: National Institute of Environmental Health Sciences; 1997.
- Henriette's Herbal: Hydrastis
- Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. 2007; pp. 226-227.
- Bradwejn J, Zhou Y, Koszycki D, Shlik J. A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. Journal of Clinical Psychopharmacology. 2000;20(6):680-684.
- Hausen BM. Centella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer. Contact Dermatitis. 1993;29(4):175-179.
- Cataldo A, Gasbarro V, et al. Effectiveness of the combination of alpha tocopherol, rutin, melilotus, and Centella asiatica in the treatment of patients with chronic venous insufficiency. Minerva Cardioangiologica. 2001 Apr;49(2):159-163.
- Wikipedia: Gotu Kola medicinal effects
- American Cancer Society: Gotu Kola
- CSIRO publication on kava
- American Cancer Society: Kava
- Kava safety library
- NCCAM: Kava
- American Cancer Society: Pau D'Arco
- Canadian Poisonous Plants Information System: Pokeweed
- Plants for a Future: Phytolacca americana
- PubMed PMID: 315368
- MedlinePlus: Pokeweed poisoning
- American Cancer Society: Pokeweed
- MedlinePlus Natural Medicines: Vitamin A
- MedlinePlus: Vitamin A
- NIH Office of Dietary Supplements: Vitamin A
- WHO: Vitamin A deficiency
- Latham ME. Human Nutrition in the Developing World. FAO Food and Nutrition Paper. Food & Agriculture Organization of the United Nations; 1997. ISBN 92-5-103818-X.
- Sommer A. Vitamin A Deficiency and Its Consequences: A Field Guide to Detection and Control. Geneva: World Health Organization; 1995. ISBN 92-4-154478-3.
- UNICEF: A World Fit for Children